ResearcherTohoku UniversityNo recent work listed
Kazuharu Chiba
Matched on OpenAlex author ID A5110817351. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 1 paper · 2022: 2 papers
Papers 3
- Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancer. First author DOI 10.1002/ags3.12597↗
- Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases. Co-author DOI 10.1245/s10434-021-10997-w↗
- MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy. Co-author DOI 10.1245/s10434-020-09440-3↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tatsuo Hata · 3 shared papers, 2021–2022 · strength 0.42
- Paper Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pa… DOI 10.1002/ags3.12597↗
- Paper Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Ab… DOI 10.1245/s10434-021-10997-w↗
- Paper MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing … DOI 10.1245/s10434-020-09440-3↗
- Kei Nakagawa · 3 shared papers, 2021–2022 · strength 0.42
- Paper Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pa… DOI 10.1002/ags3.12597↗
- Paper Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Ab… DOI 10.1245/s10434-021-10997-w↗
- Paper MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing … DOI 10.1245/s10434-020-09440-3↗
- Masamichi Mizuma · 3 shared papers, 2021–2022 · strength 0.42
- Paper Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pa… DOI 10.1002/ags3.12597↗
- Paper Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Ab… DOI 10.1245/s10434-021-10997-w↗
- Paper MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing … DOI 10.1245/s10434-020-09440-3↗
- Takanori Morikawa · 3 shared papers, 2021–2022 · strength 0.42
- Paper Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pa… DOI 10.1002/ags3.12597↗
- Paper Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Ab… DOI 10.1245/s10434-021-10997-w↗
- Paper MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing … DOI 10.1245/s10434-020-09440-3↗
- Michiaki Unno · 3 shared papers, 2021–2022 · strength 0.42
- Paper Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pa… DOI 10.1002/ags3.12597↗
- Paper Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Ab… DOI 10.1245/s10434-021-10997-w↗
- Paper MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing … DOI 10.1245/s10434-020-09440-3↗
- Fuyuhiko Motoi · 2 shared papers, 2022 · strength 0.29
- Paper Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pa… DOI 10.1002/ags3.12597↗
- Paper Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Ab… DOI 10.1245/s10434-021-10997-w↗
- Kei Kawaguchi · 1 shared paper, 2022 · strength 0.14
- Tatsuyuki Takadate · 1 shared paper, 2022 · strength 0.14
- Shuichi Aoki · 1 shared paper, 2022 · strength 0.14
- Toru Furukawa · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.